Welcome to Scribd. Sign in or start your free trial to enjoy unlimited e-books, audiobooks & documents.Find out more
Download
Standard view
Full view
of .
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Mergent XXII

Mergent XXII

Ratings: (0)|Views: 2,474|Likes:
Published by calibrateconfidence
Mergent XXII
Mergent XXII

More info:

Published by: calibrateconfidence on Mar 07, 2014
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

03/12/2014

pdf

text

original

 
03/07/20141Mergent, Inc.
22nd Century Group Inc
General Company Information
Principal Office
9530 Main StreetClarence, NY 14031 USA
Phone
716 270-1523
Auditor
Freed Maxick CPAs, P.C.
Number of Employees
9 (Year End Average Staff as of 12/31/2013)
Country of Incorporation
United States
Exchange And Ticker
OTC : XXII
Primary SIC
2111 : Cigarettes
Company Website
www.xxiicentury.com
Primary NAICS
312221 : Cigarette Manufacturing
Closing Stock Price
4.25 (as of 03/06/2014)
Incorporated
September 2005 , NV, United States
Mergent Dividend Achiever
No
Number of Shareholders
89 (record) (as of 01/28/2014)
Business Summary
 
22nd Century Group, through its 22nd Century Limited, LLC subsidiary, is a plant biotechnology company focused technology that allows for the level of nicotine and other nicotinic alkaloids (such as nornicotine, anatabine and anabasine) in tobacco plants to be decreased or increased through genetic engineering and plant breeding. 22nd Century Ltd's subsidiaries are: Hercules Pharmaceuticals LLC, which is focused on X-22, a tobacco-based botanical medical product for use as a smoking cessation therapy; and Goodrich Tobacco Company, LLC, which is focused on commercial tobacco products and potential modified risk cigarettes, and has two cigarette brands, RED SUN and MAGIC.
 
22nd Century Group Inc03/07/20142Mergent, Inc.
Company Details
Pricing Summary
Time Period: 1 week 
Yesterday5 Days30 DaysClose
4.254.342.41
Volume
189,264.00N/A233,558.00
52 Week High/Low :
4.49 - 0.58
% Price Change (100 Days) :
248.36
200-Day Moving Avg. :
1.80
Company News
11:20AM, 13 February 2014 - Profile Updates on 22nd Century Group, Inc. (OTCBB: XXII) - SBWire7:27AM, 11 February 2014 - 22nd Century Group Files For NYSE MKT Listing and NASDAQ Capital Market Listing - OTC Markets Group3:01PM, 30 January 2014 - 22nd Century Group Files Annual Report and Provides Business Update - Benzinga10:13AM, 15 January 2014 - 22nd Century Limited - Not Exactly Offering A Cure For Cancer, But Maybe The Next Best Thing - Seeking Alpha9:33AM, 10 December 2013 - 22nd Century Group Appoints Richard M. Sanders to Board of Directors - Seeking Alpha4:15PM, 5 December 2013 - 22nd Century purchases equipment out of bankruptcy - Tobacco Reporter5:38PM, 4 December 2013 - European patent allowed for 22nd Century's nicotine biosynthesis genes - Biofuels Digest10:09AM, 29 November 2013 - European Patent Allowed for 22nd Century's Nicotine Biosynthesis Genes - StreetInsider.com11:53AM, 19 November 2013 - 22nd Century Is Worth Twice Today's Shareprice - Seeking Alpha7:15AM, 14 October 2013 - 22nd Century Limited (XXII) - British American Tobacco Deal Validates
 
22nd Century Group Inc03/07/20143Mergent, Inc.
Huge Potential - Seeking Alpha
Corporate Events
There is currently no corporate events associated with this company.
Key Executives
Henry Sicignano
AgeSalary
President,Interim Chief Financial Officer,Secretary45150,000Joseph Pandolfino
AgeSalary
Chief Executive Officer44150,000John Brodfuehrer
AgeSalary
Chief Financial Officer,Treasurer55110,000Michael Moynihan
Salary
Subsidiary Officer115,000Joseph DunnDirector
Key Financials
(In USD as of 12/31/2013)
Income Statement
Revenue7mNet Income-26mEPS from Continuing Operations-0.60EPS - Net Income - Diluted-0.60Revenue per Share0.17
Balance Sheet
Total Assets12mTotal Liabilities5mShareholders' Equity8mTotal Assets per Share0.22Net Assets per Share0.13
Cash Flows
Cash from Operations4mCash from Investing-4mCash from Financing6mCapital Expenditures3mCash Flow per Share0.09
Financial Highlights
Financial Highlights as of 12/31/2013 in USD

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->